Fulgent Property Plant Equipment vs Non Current Assets Total Analysis

FLGT Stock

USD 20.77 0.10 0.48%

Fulgent Genetics financial indicator trend analysis is much more than just examining Fulgent Genetics latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Fulgent Genetics is a good investment. Please check the relationship between Fulgent Genetics Property Plant Equipment and its Non Current Assets Total accounts. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Fulgent Genetics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price.

For more information on how to buy Fulgent Stock please use our How to Invest in Fulgent Genetics guide.

Property Plant Equipment vs Non Current Assets Total

Property Plant Equipment vs Non Current Assets Total Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Fulgent Genetics Property Plant Equipment account and Non Current Assets Total. At this time, the significance of the direction appears to have almost identical trend.

The correlation between Fulgent Genetics' Property Plant Equipment and Non Current Assets Total is 0.94. Overlapping area represents the amount of variation of Property Plant Equipment that can explain the historical movement of Non Current Assets Total in the same time period over historical financial statements of Fulgent Genetics, assuming nothing else is changed. The correlation between historical values of Fulgent Genetics' Property Plant Equipment and Non Current Assets Total is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Property Plant Equipment of Fulgent Genetics are associated (or correlated) with its Non Current Assets Total. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Non Current Assets Total has no effect on the direction of Property Plant Equipment i.e., Fulgent Genetics' Property Plant Equipment and Non Current Assets Total go up and down completely randomly.

Correlation Coefficient

0.94

Relationship Direction	Positive
Relationship Strength	Very Strong

View All Relationships

Property Plant Equipment

Non Current Assets Total

The total value of a company's long-term assets, which are not expected to be converted into cash or used up within one year or the operating cycle, including property, plant, and equipment, and intangible assets.

Most indicators from Fulgent Genetics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Fulgent Genetics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Fulgent Genetics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price.

For more information on how to buy Fulgent Stock please use our How to Invest in Fulgent Genetics guide.At this time, Fulgent Genetics' Discontinued Operations is comparatively stable compared to the past year. Selling General Administrative is likely to gain to about 93.4 M in 2024, whereas Tax Provision is likely to drop slightly above 2.5 M in 2024.

	2021	2022	2023	2024 (projected)
Gross Profit	777.1M	366.9M	96.6M	179.1M
Total Revenue	992.6M	619.0M	289.2M	266.7M

Gross Profit Total Revenue

Fulgent Genetics fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Net Tangible Assets	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Property Plant Equipment	Common Stock Total Equity	Common Stock	Other Liab
Total Assets		0.92	0.85	1.0	0.99	0.98	-0.87	0.98	0.85	0.87	0.82	-0.15	0.43	0.79	0.66	0.93	0.66	0.51	0.81	0.96	0.97	0.83	0.96	-0.59	-0.59	0.81
Other Current Liab	0.92		0.93	0.91	0.9	0.9	-0.78	0.85	0.94	0.81	0.74	-0.33	0.24	0.87	0.8	0.86	0.8	0.36	0.7	0.98	0.87	0.92	0.88	-0.58	-0.58	0.72
Total Current Liabilities	0.85	0.93		0.84	0.83	0.76	-0.84	0.78	1.0	0.91	0.48	-0.3	0.48	0.83	0.91	0.88	0.9	0.07	0.83	0.89	0.72	0.91	0.72	-0.56	-0.56	0.47
Total Stockholder Equity	1.0	0.91	0.84		0.99	0.98	-0.87	0.99	0.84	0.86	0.81	-0.15	0.43	0.79	0.65	0.93	0.64	0.52	0.82	0.95	0.97	0.83	0.96	-0.59	-0.59	0.81
Net Tangible Assets	0.99	0.9	0.83	0.99		0.98	-0.91	0.97	0.82	0.88	0.81	-0.04	0.47	0.72	0.68	0.92	0.68	0.48	0.84	0.96	0.96	0.77	0.96	-0.6	-0.6	0.79
Property Plant And Equipment Net	0.98	0.9	0.76	0.98	0.98		-0.79	0.96	0.77	0.77	0.91	-0.14	0.27	0.76	0.57	0.88	0.58	0.64	0.71	0.95	1.0	0.79	1.0	-0.59	-0.59	0.9
Net Debt	-0.87	-0.78	-0.84	-0.87	-0.91	-0.79		-0.83	-0.82	-0.98	-0.51	-0.19	-0.77	-0.53	-0.82	-0.87	-0.82	-0.09	-0.97	-0.85	-0.76	-0.63	-0.74	0.56	0.56	-0.46
Retained Earnings	0.98	0.85	0.78	0.99	0.97	0.96	-0.83		0.77	0.82	0.81	-0.17	0.42	0.78	0.55	0.88	0.55	0.58	0.78	0.89	0.96	0.79	0.95	-0.48	-0.48	0.83
Accounts Payable	0.85	0.94	1.0	0.84	0.82	0.77	-0.82	0.77		0.89	0.5	-0.32	0.43	0.85	0.9	0.89	0.9	0.1	0.81	0.89	0.73	0.92	0.73	-0.6	-0.6	0.49
Cash	0.87	0.81	0.91	0.86	0.88	0.77	-0.98	0.82	0.89		0.47	0.07	0.74	0.63	0.85	0.91	0.85	0.06	0.98	0.85	0.74	0.72	0.72	-0.57	-0.57	0.43
Non Current Assets Total	0.82	0.74	0.48	0.81	0.81	0.91	-0.51	0.81	0.5	0.47		-0.16	-0.08	0.64	0.26	0.65	0.27	0.86	0.37	0.8	0.93	0.62	0.94	-0.44	-0.44	0.99
Non Currrent Assets Other	-0.15	-0.33	-0.3	-0.15	-0.04	-0.14	-0.19	-0.17	-0.32	0.07	-0.16		0.45	-0.69	-0.02	-0.18	0.0	-0.27	0.15	-0.14	-0.17	-0.6	-0.17	0.13	0.13	-0.28
Other Assets	0.43	0.24	0.48	0.43	0.47	0.27	-0.77	0.42	0.43	0.74	-0.08	0.45		0.05	0.56	0.5	0.54	-0.36	0.84	0.33	0.24	0.15	0.21	-0.24	-0.24	-0.11
Cash And Short Term Investments	0.79	0.87	0.83	0.79	0.72	0.76	-0.53	0.78	0.85	0.63	0.64	-0.69	0.05		0.55	0.81	0.55	0.46	0.53	0.78	0.77	0.99	0.77	-0.53	-0.53	0.7
Net Receivables	0.66	0.8	0.91	0.65	0.68	0.57	-0.82	0.55	0.9	0.85	0.26	-0.02	0.56	0.55		0.71	1.0	-0.24	0.79	0.78	0.5	0.68	0.51	-0.5	-0.5	0.19
Common Stock Shares Outstanding	0.93	0.86	0.88	0.93	0.92	0.88	-0.87	0.88	0.89	0.91	0.65	-0.18	0.5	0.81	0.71		0.7	0.34	0.88	0.88	0.86	0.85	0.85	-0.78	-0.78	0.65
Inventory	0.66	0.8	0.9	0.64	0.68	0.58	-0.82	0.55	0.9	0.85	0.27	0.0	0.54	0.55	1.0	0.7		-0.23	0.78	0.79	0.5	0.68	0.52	-0.48	-0.48	0.2
Other Current Assets	0.51	0.36	0.07	0.52	0.48	0.64	-0.09	0.58	0.1	0.06	0.86	-0.27	-0.36	0.46	-0.24	0.34	-0.23		0.0	0.41	0.7	0.36	0.7	-0.22	-0.22	0.9
Other Stockholder Equity	0.81	0.7	0.83	0.82	0.84	0.71	-0.97	0.78	0.81	0.98	0.37	0.15	0.84	0.53	0.79	0.88	0.78	0.0		0.76	0.67	0.62	0.65	-0.6	-0.6	0.35
Total Liab	0.96	0.98	0.89	0.95	0.96	0.95	-0.85	0.89	0.89	0.85	0.8	-0.14	0.33	0.78	0.78	0.88	0.79	0.41	0.76		0.92	0.84	0.93	-0.59	-0.59	0.76
Property Plant And Equipment Gross	0.97	0.87	0.72	0.97	0.96	1.0	-0.76	0.96	0.73	0.74	0.93	-0.17	0.24	0.77	0.5	0.86	0.5	0.7	0.67	0.92		0.78	1.0	-0.56	-0.56	0.93
Total Current Assets	0.83	0.92	0.91	0.83	0.77	0.79	-0.63	0.79	0.92	0.72	0.62	-0.6	0.15	0.99	0.68	0.85	0.68	0.36	0.62	0.84	0.78		0.78	-0.57	-0.57	0.66
Property Plant Equipment	0.96	0.88	0.72	0.96	0.96	1.0	-0.74	0.95	0.73	0.72	0.94	-0.17	0.21	0.77	0.51	0.85	0.52	0.7	0.65	0.93	1.0	0.78		-0.57	-0.57	0.93
Common Stock Total Equity	-0.59	-0.58	-0.56	-0.59	-0.6	-0.59	0.56	-0.48	-0.6	-0.57	-0.44	0.13	-0.24	-0.53	-0.5	-0.78	-0.48	-0.22	-0.6	-0.59	-0.56	-0.57	-0.57		1.0	-0.41
Common Stock	-0.59	-0.58	-0.56	-0.59	-0.6	-0.59	0.56	-0.48	-0.6	-0.57	-0.44	0.13	-0.24	-0.53	-0.5	-0.78	-0.48	-0.22	-0.6	-0.59	-0.56	-0.57	-0.57	1.0		-0.41
Other Liab	0.81	0.72	0.47	0.81	0.79	0.9	-0.46	0.83	0.49	0.43	0.99	-0.28	-0.11	0.7	0.19	0.65	0.2	0.9	0.35	0.76	0.93	0.66	0.93	-0.41	-0.41

Click cells to compare fundamentals

Fulgent Genetics Account Relationship Matchups

Fulgent Genetics fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	88.8M	700.5M	1.3B	1.4B	1.3B	1.3B
Other Current Liab	3.6M	62.7M	36.7M	58.4M	49.1M	51.6M
Total Current Liabilities	6.0M	131.1M	112.8M	116.2M	73.0M	49.4M
Total Stockholder Equity	82.8M	569.4M	1.2B	1.3B	1.1B	1.2B
Net Tangible Assets	82.8M	569.4M	1.2B	973.0M	1.1B	1.2B
Property Plant And Equipment Net	6.0M	40.2M	62.3M	81.4M	94.3M	99.0M
Net Debt	(9.3M)	(71.6M)	(164.9M)	(58.9M)	(82.6M)	(78.4M)
Retained Earnings	(63.4M)	150.9M	657.6M	801M	633.2M	664.8M
Accounts Payable	1.6M	26.5M	20.5M	23.1M	15.4M	10.3M
Cash	12.0M	87.4M	164.9M	79.5M	97.5M	50.9M
Non Current Assets Total	12.0M	84.7M	62.3M	480.4M	765.3M	803.5M
Non Currrent Assets Other	(36.8M)	(88.0M)	142.0M	(287.4M)	32.0M	33.6M
Other Assets	251K	44.5M	912.6M	26.6M	1.0	0.95
Cash And Short Term Investments	70.2M	431.9M	164.9M	852.9M	424.2M	227.7M
Net Receivables	6.6M	183.9M	138.9M	52.7M	57.4M	50.2M
Common Stock Shares Outstanding	18.7M	24.1M	31.2M	31.0M	29.8M	23.5M
Liabilities And Stockholders Equity	88.8M	700.5M	1.3B	1.4B	1.3B	1.3B
Inventory	277K	16.5M	12.2M	4.3M	5.8M	4.4M
Other Current Assets	277K	(16.5M)	(12.2M)	22.2M	26.2M	27.6M
Other Stockholder Equity	146.1M	418.1M	1.2B	477.4M	481.3M	332.8M
Total Liab	6.0M	131.1M	112.8M	116.2M	139.8M	146.8M
Property Plant And Equipment Gross	8.6M	41.0M	81.9M	124.6M	135.1M	141.9M
Total Current Assets	76.8M	615.7M	303.8M	905.6M	507.8M	280.8M
Accumulated Other Comprehensive Income	146K	438K	(759K)	(20.9M)	1.2M	1.3M
Property Plant Equipment	8.6M	40.2M	62.3M	98.9M	113.8M	119.4M
Retained Earnings Total Equity	(63.0M)	(63.4M)	150.9M	657.6M	756.2M	794.0M
Short Term Investments	58.3M	344.4M	770.7M	773.4M	326.7M	326.9M
Non Current Liabilities Total	2.3M	959K	7.5M	28.1M	66.8M	70.1M
Capital Surpluse	114.2M	146.1M	418.1M	501.9M	577.2M	606.1M
Long Term Investments	42.8M	132.5M	507.0M	339.0M	444.0M	466.2M
Non Current Liabilities Other	2.3M	959K	7.5M	28.1M	11.0M	6.8M
Net Invested Capital	82.8M	584.4M	1.2B	1.3B	1.1B	688.3M
Net Working Capital	33.4M	393.5M	961.6M	539.8M	434.8M	381.8M

Pair Trading with Fulgent Genetics

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Fulgent Genetics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Fulgent Genetics will appreciate offsetting losses from the drop in the long position's value.

Moving together with Fulgent Stock

0.76

Laboratory

Pair Corr

The ability to find closely correlated positions to Fulgent Genetics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Fulgent Genetics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Fulgent Genetics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Fulgent Genetics to buy it.

The correlation of Fulgent Genetics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Fulgent Genetics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Fulgent Genetics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Fulgent Genetics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

Additional Tools for Fulgent Stock Analysis

When running Fulgent Genetics' price analysis, check to measure Fulgent Genetics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fulgent Genetics is operating at the current time. Most of Fulgent Genetics' value examination focuses on studying past and present price action to predict the probability of Fulgent Genetics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fulgent Genetics' price. Additionally, you may evaluate how the addition of Fulgent Genetics to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC